GPCM
AEON.WS

Granite Point Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Granite Point Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-66,666
Closed -$2K – 105
2022
Q4 		$2K Hold
66,666
– – ﹤0.01% 90
2022
Q3 		$5K Hold
66,666
– – ﹤0.01% 102
2022
Q2 		$10K Hold
66,666
– – ﹤0.01% 106
2022
Q1 		$20K Hold
66,666
– – ﹤0.01% 124
2021
Q4 		$34K Hold
66,666
– – 0.01% 126
2021
Q3 		$37K Hold
66,666
– – ﹤0.01% 134
2021
Q2 		$67K Buy
+66,666
New +$50.6K ﹤0.01% 156

Other funds holding AEON.WS

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Granite Point Capital Management's AEON.WS Position: Q1 2023 in Review

Granite Point Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q1 2023, closing a stake of 66,666 shares — an estimated $2K sold.

Granite Point Capital Management first reported a position in AEON.WS in Q2 2021 and held it in 7 quarters. The position peaked at $67K in Q2 2021. 49 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2023.

  • Granite Point Capital Management reported no remaining AEON Biopharma Inc position as of Q1 2023 after selling out during the quarter.
  • Granite Point Capital Management sold 66,666 AEON Biopharma Inc shares in Q1 2023, an estimated $2K.
  • Granite Point Capital Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 7 quarters.
  • Granite Point Capital Management's AEON Biopharma Inc position peaked at $67K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2023.

Based on Granite Point Capital Management's 13F filing for Q1 2023, filed 11 May 2023.